Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WIC update

This article was originally published in The Tan Sheet

Executive Summary

The Special Supplemental Nutrition Program for Woman, Infants and Children (WIC) has been updated to encourage breastfeeding, according to a notice published in the Aug. 7 Federal Register. The proposed rule would "establish two infant feeding options for the first month after birth, either full breastfeeding or full formula-feeding," as the Institutes of Medicine recommended in May 2005 1("The Tan Sheet" May 9, 2005, p. 15). A third infant feeding option is proposed for the second to eleventh month after birth - partial breastfeeding. The infant would be fed half the amount of formula for a fully breast-fed infant in addition to breastfeeding. Comments on the proposed rule must be postmarked on or before Nov. 6, 2006. This proposed rule marks the first comprehensive revisions to the WIC food package since 1980...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel